Elevance health inc.ELV.US Overview
ELV Overall Performance
ELV AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
ELV Key Information
ELV Financial Forecast
Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2025Q1 | ||||
| 2025Q2 | ||||
| 2025Q3 | ||||
| 2025Q4 | ||||
| 2026Q1 |
ELV Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
ELV Profile
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Price of ELV
ELV FAQ
When is ELV's latest earnings report released?
The most recent financial report for Elevance health inc. (ELV) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ELV's short-term business performance and financial health. For the latest updates on ELV's earnings releases, visit this page regularly.
Where does ELV fall in the P/E River chart?
According to historical valuation range analysis, Elevance health inc. (ELV)'s current price-to-earnings (P/E) ratio is 14.05, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of ELV?
According to the latest financial report, Elevance health inc. (ELV) reported an Operating Profit of 1.76B with an Operating Margin of 3.46% this period, representing a growth of 5.02% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is ELV's revenue growth?
In the latest financial report, Elevance health inc. (ELV) announced revenue of 50.71B, with a Year-Over-Year growth rate of 12.43%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does ELV have?
As of the end of the reporting period, Elevance health inc. (ELV) had total debt of 32.1B, with a debt ratio of 0.26. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does ELV have?
At the end of the period, Elevance health inc. (ELV) held Total Cash and Cash Equivalents of 8.71B, accounting for 0.07 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does ELV go with three margins increasing?
In the latest report, Elevance health inc. (ELV) achieved the “three margins increasing” benchmark, with a gross margin of 14.2%%, operating margin of 3.46%%, and net margin of 2.3%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ELV's profit trajectory and future growth potential.
Is ELV's EPS continuing to grow?
According to the past four quarterly reports, Elevance health inc. (ELV)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 5.32. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of ELV?
Elevance health inc. (ELV)'s Free Cash Flow (FCF) for the period is 775M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 66.95% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of ELV?
The latest valuation data shows Elevance health inc. (ELV) has a Price-To-Earnings (PE) ratio of 14.05 and a Price/Earnings-To-Growth (PEG) ratio of -0.49. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.